Get notified of page updates
Public Policy Priorities
Review some of FORCE's current legislative and regulatory policy priorities that impact the hereditary cancer community.

Stay up to date on research and information

Sign Up for FORCE Newsletters

Policy Archive

Bill Aims to Address Ongoing Survivorship Care Needs

Insurance Coverage & Barriers

January 2023 - With the start of a new congress, all legislation that didn't pass last year needs to be reintroduced. Stay tuned for updates on this legislation in the coming months...

Many cancer patients, survivors and thrivers experience a disjointed system as they transition from diagnosis to active treatment to more routine care. Introduced on December 14, the Comprehensive Cancer Survivorship Act (CCSA) aims to address these gaps in survivorship car. FORCE was pleased to contribute to this sweeping legislation that will establish new standards of care in an effort to ensure the best and most seamless experience for survivors, their families, and caregivers, throughout the survivorship journey, from diagnosis to end of life.

Sponsored by U.S. Representatives Mark DeSaulnier (D-CA), Brian Fitzpatrick (R-PA), Debbie Wasserman Schultz (D-FL), and Senators Amy Klobuchar (D-MN) and Ben Cardin (D-MD), the CCSA’s key pillars include:

  • Care Planning and Transition: Provides coverage to address the transition from treatment to primary care, facilitating the development of personalized care plans, guiding survivorship monitoring and follow-up care;
  • Navigation: Develops comprehensive navigation services that emphasize the continuum of care, such as follow-up screening for recurrence or new cancers, psychosocial assistance, and addressing health disparities or determinants, like food insecurity, housing, transportation, telehealth access, and childcare;
  • Quality of Care: Creates grants to encourage the use of navigation and care plans, exploration of at-home care, and better use of information technology to collect patient experience data;
  • Employment/Workforce: Establishes assistance grants to help survivors, their families, and caregivers when faced with a range of challenges such as reduced working hours and treatment-related unemployment; 
  • Fertility Preservation: Provides Medicaid coverage of fertility preservation services for those diagnosed with cancer.
  • Education/Awareness: Creates resources for survivors and healthcare professionals regarding early detection, preventive and high-quality survivorship care; 
  • Payment Model: Studies the existing coverage and reimbursement landscape to develop an alternative payment model to ensure a coordinated approach to survivorship care.

“Cancer has a lasting impact—physical, social, emotional, and financial—on the affected individual and their family. Improved screening, early detection, and therapies allow us to save more lives than ever before so understanding the needs of cancer survivors and helping them successfully navigate life after cancer is crucial. This legislation will pave the way for survivors to have better quality of life, providing guidance to address short- and long-term treatment effects, and an evidence-based plan that includes screening for recurrence, new cancers, and other complications,” Lisa Schlager, Vice President, Public Policy, FORCE.

At a press conference regarding this legislation, Representative Wasserman Schultz acknowledged the challenging work that lies ahead and called on all members of the cancer community to lend their voices to this collective effort. FORCE looks forward to working with advocates and Members of Congress to advance this effort to improve the quality of life and care for survivors.

Take Action Now Become an Advocate 2024 Priorities Federal Policy State Policy Advocacy Archive

News Briefs

4/29/2024 - Sent the Administrator of the Centers for Medicare & Medicaid Services (CMS) feedback and recommendations on its Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents.

4/3/2024 - Submitted comments to Senator Cassidy and the HELP Committee in response to an RFI regarding oversight of clinical diagnostic tests, known as in vitro diagnostics (IVDs) and laboratory-developed tests (LDTs).

3/15/2024 - Joined the Coalition to Increase Access to Cancer Care (CIACC) in comments to House leadership on efforts to strengthen the Employee Retirement Income Security Act (ERISA) and emphasize the need to pass the Cancer Drug Parity Act.

3/1/2024 - Provided feedback to CMS on the Medicare Advantage Advanced Notice and accompanying Part D Redesign Program provisions aimed at reducing and managing beneficiary out-of-pocket costs in the Medicare Part D program.